Cargando…
A structural mechanism of nuclear receptor biased agonism
Efforts to decrease the adverse effects of nuclear receptor (NR) drugs have yielded experimental agonists that produce better outcomes in mice. Some of these agonists have been shown to cause different, not just less intense, on-target transcriptomic effects; however, a structural explanation for su...
Autores principales: | Nemetchek, Michelle D., Chrisman, Ian M., Rayl, Mariah L., Voss, Andrew H., Hughes, Travis S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897460/ https://www.ncbi.nlm.nih.gov/pubmed/36469765 http://dx.doi.org/10.1073/pnas.2215333119 |
Ejemplares similares
-
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Brust, Richard, et al.
Publicado: (2018) -
Structural determinants of dual incretin receptor agonism by tirzepatide
por: Sun, Bingfa, et al.
Publicado: (2022) -
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
por: Heidari, Zahra, et al.
Publicado: (2019) -
Biased agonism
por: Kenakin, Terry
Publicado: (2009) -
Structural analysis of the dual agonism at GLP-1R and GCGR
por: Li, Yang, et al.
Publicado: (2023)